Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome

Clinical trial NCT00640276 · COMPLETED

Trial details

NCT number: NCT00640276
Sponsor: JW Pharmaceutical
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypercholesterolemia Metabolic Syndrome

Start date: 2008-04-01
Primary completion: 2011-02-01
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.